Pfizer Inc. First to Implement New Licensing and Education Resource
DANVERS, Mass., June 6, 2005—Copyright Clearance Center, the world's premier provider of copyright licensing and compliance solutions, today unveiled CopyRight Plus—a desktop solution that helps companies make it easier and faster for their employees to comply with copyright law. Copyright Clearance Center will demonstrate their newest offering at the Special Libraries Association (SLA) 2005 Annual Conference in Toronto, Canada June 5-8.
CopyRight Plus is a customizable, secure, Web-based solution easily accessible by employees through their companies’ intranet sites. It enables all employees to quickly verify their company’s worldwide copyright licensing coverage from Copyright Clearance Center for various uses of content from print and electronic journals, newsletters, magazines, newspapers and other materials. In addition, CopyRight Plus gives companies an efficient and consistent way to educate employees about their corporate compliance policies and responsibilities.
Pharmaceutical giant Pfizer Inc. recently became the first company to implement the new desktop solution for its more than 120,000 employees located in at least 150 countries around the globe. “CopyRight Plus gives Pfizer’s workforce an immediate and convenient way to verify that they have clearance to use and distribute content from millions of titles and it provides a centralized location for Pfizer’s information center resources,” said Robert S. Weiner, senior vice president at Copyright Clearance Center.
Industry analyst Geoffrey Bock, principal at Bock & Company, gave Copyright Clearance Center high marks for introducing such an easy-to-use solution for the corporate world. “CopyRight Plus simplifies the rights management process for information providers who are responsible for managing the purchase of rights within corporations. It is a great next step in the compliance solutions continuum.”
About Copyright Clearance Center, Inc.
Copyright Clearance Center is the world’s premier provider of copyright licensing and compliance solutions for the information content industry. A trusted intermediary between copyright holders and content users, the company facilitates the exchange of reuse rights and royalties through a wide range of licensing services. Copyright Clearance Center manages the rights to millions of works and represents more than 9,600 publishers and hundreds of thousands of authors and other creators. The company’s streamlined, convenient compliance solutions enable more than 10,000 corporations and subsidiaries, including nearly all of the Fortune 100, and thousands of government agencies, law firms, document suppliers, libraries, academic institutions, copy shops and bookstores to respect the rights of copyright holders and lawfully reuse the copyright-protected information they need to drive their business. Founded in 1978, Copyright Clearance Center is headquartered in Danvers, Massachusetts. For more information, visit copyright.com
About Pfizer Inc.
Pfizer Inc discovers, develops, manufactures, and markets leading prescription medicines for humans and animals and many of the world's best-known consumer brands. Its innovative, value-added products improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. The company has three business segments: human health, animal health and consumer health care. Its products are available in more than 150 countries. For more information, visit www.pfizer.com.
Copyright Clearance Center and the Copyright Clearance Center logo are registered trademarks of Copyright Clearance Center, Inc.